We take your personal privacy very seriously and when you visit our website, please agree to all cookies used. Further information on the processing of personal data can be found in the Privacy Statement

b1_banpc.jpg b1_banph.jpg

About Us

About Full-Life Technologies

Full-Life Technologies Limited (“Full-Life”) is a fully integrated global radiotherapeutics company with operations in Europe, the United States, and China. We seek to own the entire value chain for radiopharmaceutical research & development, production & commercialization in order to deliver clinical impact for patients. The company plans to attack core issues affecting radiopharmaceuticals today through innovative research that targets the treatments of tomorrow. 

We are comprised of a team of fast-moving entrepreneurs and scientists with a demonstrated track record in the life sciences, as well as radioisotope research and clinical development. 

  • Leadership Team

  • b1_img1.jpg
    Lanny Sun
    Co-founder, Chairman & Chief Executive Officer
  • b1_img9.jpg
    Steffen Heeger, MD, Ph.D.
    Chief Medical Officer
  • b1_img8.jpg
    Fa Liu, Ph.D.
    Chief Scientific Officer
  • b1_img2.jpg
    Hong-hoi Ting, D.Phil.
    Co-founder, Board Member & Chief Strategy Officer
  • b1_img5.jpg
    Philippe van Put
    General Manager, Europe
  • b1_img4.jpg
    Nicholas Wong, Ph.D.
    Co-founder & Chief Operating Officer
  • b1_img6.jpg
    Julie Wu
    Chief Financial Officer
  • b1_img7.png
    James McCarter, Ph.D.
    Vice President & Head of Radioisotope Technology Research
  • 2023. 5
    Full-Life Technologies completed land purchase in Belgium to establish GMP manufacturing facility for radiopharmaceutical drug production

    2023. 5

  • 2023. 1
    Full-Life Technologies Announces Appointment of Chief Medical Officer and Chief Scientific Officer

    2023. 1

  • 2022.11
    Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-Focused Radiopharmaceutical Pipeline


  • 2022. 8
    Full-Life Technologies Announces Key Leadership Appointments and the Establishment of a Radioisotope Technology Advisory Board

    2022. 8

  • 2022. 5
    Full-Life Technologies completed $37 million in series A round financing.

    2022. 5

  • 2022. 1
    Full-Life Technologies announced four key appointments to its executive team.

    2022. 1

  • 2021. 12
    Full-Life Technologies completed $10 million in seed round financing.

    2021. 12

  • 2021. 8
    Full-Life Technologies was Founded.

    2021. 8